[Therapy-related leukemia]

Nihon Naika Gakkai Zasshi. 2003 Jun 10;92(6):1007-12.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Alkylating / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Chromosomes, Human, Pair 11 / genetics
  • DNA-Binding Proteins / genetics
  • Enzyme Inhibitors / adverse effects
  • Gene Deletion
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Leukemia* / etiology
  • Leukemia* / therapy
  • Myeloid-Lymphoid Leukemia Protein
  • Neoplasms, Second Primary* / etiology
  • Neoplasms, Second Primary* / therapy
  • Proto-Oncogenes*
  • Topoisomerase II Inhibitors
  • Transcription Factors*
  • Translocation, Genetic / drug effects

Substances

  • Antineoplastic Agents, Alkylating
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • KMT2A protein, human
  • Topoisomerase II Inhibitors
  • Transcription Factors
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase